These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 26912625)

  • 1. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.
    Plante JA; Torres M; Huang CY; Beasley DWC
    Virology; 2016 Sep; 496():97-105. PubMed ID: 27284640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural gene (prME) chimeras of St Louis encephalitis virus and West Nile virus exhibit altered in vitro cytopathic and growth phenotypes.
    Maharaj PD; Anishchenko M; Langevin SA; Fang Y; Reisen WK; Brault AC
    J Gen Virol; 2012 Jan; 93(Pt 1):39-49. PubMed ID: 21940408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.
    Goo L; VanBlargan LA; Dowd KA; Diamond MS; Pierson TC
    PLoS Pathog; 2017 Feb; 13(2):e1006178. PubMed ID: 28207910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.
    Zhang S; Bovshik EI; Maillard R; Gromowski GD; Volk DE; Schein CH; Huang CY; Gorenstein DG; Lee JC; Barrett AD; Beasley DW
    Virology; 2010 Jul; 403(1):85-91. PubMed ID: 20447672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.
    Basset J; Burlaud-Gaillard J; Feher M; Roingeard P; Rey FA; Pardigon N
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2.
    Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF
    J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.
    Pierson TC; Sánchez MD; Puffer BA; Ahmed AA; Geiss BJ; Valentine LE; Altamura LA; Diamond MS; Doms RW
    Virology; 2006 Mar; 346(1):53-65. PubMed ID: 16325883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
    Chu JH; Chiang CC; Ng ML
    J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
    Li L; Barrett AD; Beasley DW
    Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop.
    Chabierski S; Barzon L; Papa A; Niedrig M; Bramson JL; Richner JM; Palù G; Diamond MS; Ulbert S
    BMC Infect Dis; 2014 May; 14():246. PubMed ID: 24884467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. West Nile and St. Louis encephalitis viral genetic determinants of avian host competence.
    Maharaj PD; Bosco-Lauth AM; Langevin SA; Anishchenko M; Bowen RA; Reisen WK; Brault AC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006302. PubMed ID: 29447156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody to DIII E protein allowing the differentiation of West Nile virus from other flaviviruses by a lateral flow assay.
    Rebollo B; Pérez T; Camuñas A; Pérez-Ramírez E; Llorente F; Sánchez-Seco MP; Jiménez-Clavero MÁ; Venteo Á
    J Virol Methods; 2018 Oct; 260():41-44. PubMed ID: 29958922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
    Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
    J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E glycoprotein plays an essential role in the high pathogenicity of European-Mediterranean IS98 strain of West Nile virus.
    Alsaleh K; Khou C; Frenkiel MP; Lecollinet S; Vàzquez A; de Arellano ER; Després P; Pardigon N
    Virology; 2016 May; 492():53-65. PubMed ID: 26896935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.
    Kanai R; Kar K; Anthony K; Gould LH; Ledizet M; Fikrig E; Marasco WA; Koski RA; Modis Y
    J Virol; 2006 Nov; 80(22):11000-8. PubMed ID: 16943291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bagaza virus inhibits Japanese encephalitis & West Nile virus replication in Culex tritaeniorhynchus & Cx. quinquefasciatus mosquitoes.
    Sudeep AB; Bondre VP; George R; Ghodke YS; Aher RV; Gokhale MD
    Indian J Med Res; 2015 Dec; 142 Suppl(Suppl 1):S44-51. PubMed ID: 26905241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues in West Nile virus pre-membrane protein that influence viral particle secretion and virulence.
    Setoh YX; Prow NA; Hobson-Peters J; Lobigs M; Young PR; Khromykh AA; Hall RA
    J Gen Virol; 2012 Sep; 93(Pt 9):1965-1975. PubMed ID: 22764317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.